ESC 365 - Empagliflozin inhibits increased Na influx in HFpEF cardiomyocytes and reduces arrhythmic activity in human atrial trabeculae

ESC Professional Premium Access

Empagliflozin inhibits increased Na influx in HFpEF cardiomyocytes and reduces arrhythmic activity in human atrial trabeculae

Session: Young Investigator Awards Session in Basic Science

Topic: Heart Failure

Speaker: Doctor M. Trum (Regensburg, DE)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Maximilian Trum

University Hospital Regensburg, Regensburg (Germany)

0 follower

3 more presentations in this session

Aberrant interaction between TEAD1 and Lamin A/C causes cardiomyopathy

Speaker: Doctor S. Yamada (Tokyo, JP)

Atrial-specific reduction of Kir2.1 channel pore diameter in addition to loss of inward-going rectification underlies inducible atrial fibrillation in a mouse model of short QT syndrome type 3

Speaker: Miss A. Moreno Manuel (Madrid, ES)

Single-cell transcriptomics reveals an angiogenic cell population for therapeutic angiogenesis in adipose tissue

Speaker: Doctor O. Inoue (Cincinnati, US)

Access the full session

Young Investigator Awards Session in Basic Science

Speakers: Doctor M. Trum, Doctor S. Yamada, Miss A. Moreno Manuel, Doctor O. Inoue

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources